April 16, 2026

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.

Conexiant

April 06, 2026

The Loan Cap That Could Shrink the Doctor Pipeline

New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.

Conexiant

March 31, 2026

Postzoster Neuralgia Linked to Tinnitus

Nationwide cohort analysis finds higher tinnitus incidence during long-term follow-up among patients with postzoster neuralgia, particularly older patients and certain comorbidities.

Conexiant

March 27, 2026

ACSM Revises Resistance Training Guidance

Synthesized evidence clarifies which training variables enhance strength, hypertrophy, and performance.

Conexiant

March 23, 2026

Fibromyalgia Drugs Tested for Value

Investigators compare common fibromyalgia therapies.

Conexiant

March 19, 2026

Sleep Apnea Device Receives FDA Approval

Randomized trial data support the approval, with sustained improvements in apnea severity observed.

Conexiant

March 17, 2026

Side Effects: When the Obvious Call Is the Wrong One

Dialysis, nicotine, caffeine, and tattoos — four studies that quietly rearrange what good clinical instinct looks like.

Conexiant

January 03, 2025

Online Recruitment Fraud: Challenges and Strategies

Explore strategies to identify and mitigate fraudulent responses in online health research, with exclusion rates reaching up to 94%.

Conexiant

January 07, 2025

Patient Insights on HRQOL in Chronic GVHD

Explore how cutaneous graft-versus-host disease impacts patients’ quality of life across physical, psychological, and social domains.

Conexiant

January 08, 2025

Modified Consent May Aid Psychedelic Trials

Researchers at the University of California, San Francisco propose modifications to informed consent procedures in psychedelic drug trials, aiming to balance scientific rigor and ethical standards.

Conexiant